Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 13.07.2026 1 Ann Surg Oncol 1 Cancer 1 Int J Cancer 2 J Am Acad Dermatol 3 Melanoma Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. READ T, Nair G, Velli G, David M, et al
   A Systematic Review and Meta-Analysis of Surgical Feasibility and Outcomes Following Neoadjuvant Immune Checkpoint Inhibition in Resectable Stage III and IV Melanoma.
   Ann Surg Oncol. 2026 Jul 9. doi: 10.1245/s10434-026-20067.
   PubMed         Abstract available
   
   

   
   Cancer

2. BERCIANO-GUERRERO MA, Perez-Ruiz E, Soria A, Medina Martinez J, et al
   Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.
   Cancer. 2026;132:e70497.
   PubMed         Abstract available
   
   

   
   Int J Cancer

3. JAVAID A, Peres T, Schmitt AM, Larkin J, et al
   10-Years of First-Line Ipilimumab and Nivolumab in Advanced Melanoma: A Single Centre Experience.
   Int J Cancer. 2026 Jul 9. doi: 10.1002/ijc.70653.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

4. CHEN J, Fernandez K, Tang AS, Zhong X, et al
   Differential melanoma outcomes in a regional VA center and a tertiary care center with shared physician staffing: A cohort study.
   J Am Acad Dermatol. 2026 Jul 8:S0190-9622(26)03085.
   PubMed         Abstract available
   
   
5. TOOBA F, Khan AM, Talha M, Shah SA, et al
   Re: Effect of anatomical site on prognosis and progression pattern in early-stage acral melanoma: A retrospective cohort study of 281 cases.
   J Am Acad Dermatol. 2026 Jul 4:S0190-9622(26)03040.
   PubMed        
   
   

   
   Melanoma Res

6. BRUNO S, Knight AD, Layding CJ, Wang H, et al
   Nectin-4 as predictive biomarker of immune-related adverse event subtypes in adjuvant anti-programmed-death-1 treatment of melanoma.
   Melanoma Res. 2026 Jul 9. doi: 10.1097/CMR.0000000000001122.
   PubMed         Abstract available
   
   
7. GONG Z, Zhang F, Feng Y, Wu L, et al
   Dissecting cellular heterogeneity across two ocular melanoma subtypes by single-cell RNA sequencing.
   Melanoma Res. 2026 Jul 7. doi: 10.1097/CMR.0000000000001119.
   PubMed         Abstract available
   
   
8. LIU W, Xu Y, Yang Y, Taadolkhah M, et al
   An online cutaneous melanoma risk screen tool.
   Melanoma Res. 2026 Jul 7. doi: 10.1097/CMR.0000000000001121.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum